ストックスクリーナーアプリを入手
2.40
4.80%
0.11
前日終値:
$2.29
開ける：
$2.32
24時間の取引高:
1,884
Relative Volume:
0.25
時価総額：
$9.70M
収益：
$33.36M
当期純損益:
$-10.83M
株価収益率:
-7.7419
EPS:
-0.31
ネットキャッシュフロー:
$-5.54M
1週間 パフォーマンス:
+3.00%
1か月 パフォーマンス:
-1.23%
6か月 パフォーマンス:
-17.53%
1年 パフォーマンス:
-20.27%
1日の値動き範囲:
$2.31
$2.40
1週間の範囲:
$2.2001
$2.50
52週間の値動き範囲:
$2.10
$3.80
Strata Skin Sciences Inc Stock (SSKN) Company Profile
名前
Strata Skin Sciences Inc
セクター
電話
215-619-3200
住所
5 WALNUT GROVE DRIVE, HORSHAM, PA
SSKN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SSKN
Strata Skin Sciences Inc
|
2.40 | 9.70M | 33.36M | -10.83M | -5.54M | -0.31 |
|
ABT
Abbott Laboratories
|
136.56 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
106.52 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
397.86 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.09 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.02 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Strata Skin Sciences Inc Stock (SSKN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2019-12-09 | 開始されました | Ladenburg Thalmann | Buy |
| 2019-11-21 | 開始されました | Oppenheimer | Outperform |
| 2018-12-10 | 開始されました | Northland Capital | Outperform |
| 2017-05-16 | 繰り返されました | Rodman & Renshaw | Buy |
| 2017-02-21 | 再開されました | Rodman & Renshaw | Buy |
Strata Skin Sciences Inc (SSKN) 最新ニュース
Short Interest in STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Rises By 112.5% - Defense World
STRATA Skin Sciences Expands Access to Excimer Laser Treatments with CPT Code Updates - MSN
Pre-market Movers: HCTI, KLTO, INTS, HSDT... - RTTNews
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Short Interest Up 26.3% in May - Defense World
Vitiligo Pipeline 2025: Therapies, MOA Insights, and Key - openPR.com
Vitiligo Treatment Market Size, Share & Forecast 2024-2031 | - openPR.com
STRATA Skin Sciences (NASDAQ:SSKN) Stock Crosses Above Two Hundred Day Moving Average – Should You Sell? - Defense World
STRATA Skin Sciences Reports Q1 2025 Financial and Operational Progress - MSN
Vitiligo Market Expected to Experience Major Growth by 2034, According to DelveInsight | Pfizer, Clinuvel, Inc., Clinuvel Pharmaceuticals, Bioniz Therapeutics, TAGCyx Biotech - Barchart.com
Analysts Offer Insights on Healthcare Companies: Strata Skin Sciences (SSKN), Ionis Pharmaceuticals (IONS) and Maze Therapeutics, Inc. (MAZE) - The Globe and Mail
STRATA Skin Sciences Gains CPT Code Expansion For Excimer Laser Use In Skin Inflammatory Diseases - Nasdaq
SSKN Gains Approval Expansion for Excimer Laser Treatments | SSKN Stock News - GuruFocus
STRATA Skin Sciences Announces Historic Expansion of CPT - GlobeNewswire
Major Medicare Victory: STRATA's Skin Treatment Now Covers 30M Patients After Historic CPT Code Expansion - Stock Titan
Strata Skin Sciences outlines multi-quarter Elevate 360 expansion as recurring revenue per device rises for fourth consecutive quarter - MSN
STRATA Skin Sciences to Announce Q1 2025 Financial Results and Host Investor Call - MSN
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q1 2025 Earnings Call Transcript - Insider Monkey
STRATA Skin Sciences First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
STRATA Skin Sciences to Join D. Boral Capital’s Inaugural Global Conference in NYC - MSN
Zentalis Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Progress - The Manila Times
STRATA Skin Sciences Reports Q1 2025 Financial Results - TipRanks
Earnings call transcript: STRATA Skin Sciences sees modest growth in Q1 2025 - Investing.com Canada
Strata Skin Sciences Reports Q1 2025 Financial Results - TipRanks
STRATA Skin Sciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
STRATA Skin Sciences Reports First Quarter 2025 Financial Results and Provides a Corporate Update - GlobeNewswire
Strata Skin Sciences Inc (SSKN) Q1 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus
A Peek at Strata Skin Sciences's Future Earnings - Nasdaq
STRATA Skin Sciences (SSKN) Projected to Post Quarterly Earnings on Wednesday - Defense World
STRATA Skin Sciences Inc expected to post a loss of 52 cents a shareEarnings Preview - TradingView
NEXGEL to Announce Q1 2025 Financial Results on May 13 - MyChesCo
Vertex, Inc. Reports Strong First-Quarter Growth Driven by Cloud Revenue and Strategic Investments - MyChesCo
Non-Surgical Skin Tightening Market Grows with Demand - openPR.com
STRATA Skin Sciences to Participate in the D. Boral Capital Inaugural Global Conference - GlobeNewswire
Strata Skin Sciences To Report First Quarter 2025 Financial Results On May 14, 2025 And Provide Corporate Update - marketscreener.com
STRATA Skin Sciences, Inc. to Report First Quarter 2025 Financial Results on May 14, 2025 - Nasdaq
STRATA Skin Sciences to Report First Quarter 2025 Financial Results on May 14, 2025 and Provide Corporate Update - GlobeNewswire
Cohen & Company to Announce Q1 2025 Financial Results on May 1 with Live Webcast - MyChesCo
Vitiligo Treatment Market Size & Share | Industry Growth [2032] - SkyQuest Technology
Press Release Distribution & PR Platform - ACCESS Newswire
Facial Rejuvenation Market Report 2025-2034: Industry - openPR.com
Aesthetic Lasers Market Is Booming So Rapidly | Lumenis, Viora, Sciton - openPR.com
Dermatology Excimer Laser Market Size to Hit USD 1,725.35 Million by 2034 - Precedence Research
Vertex, Inc. to Announce Q1 2025 Financial Results on May 7 - MyChesCo
Radian Group Inc. Announces Q1 2025 Earnings Call - MyChesCo
Study Validates Advantages of STRATA Skin Sciences’ XTRAC Laser Technology - MSN
The Evolution of Dermatology Devices Market: What to Expect in 2025 - WhaTech
Dermatology Excimer Laser Market Size & Share Report, 2034 - Global Market Insights
Strata Skin Sciences Inc (SSKN) 財務データ
収益
当期純利益
現金流量
EPS
Strata Skin Sciences Inc (SSKN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Accelmed Partners, L.P. | 10% Owner |
Jul 15 '24 |
Buy |
3.14 |
230,573 |
723,999 |
1,441,835 |
| Rafaeli Dolev | Chief Executive Officer |
Jul 15 '24 |
Buy |
3.14 |
19,100 |
59,974 |
143,156 |
1.35%
0.42%
大文字化:
|
ボリューム (24 時間):